Literature DB >> 8811347

Correlates of protection in HIV infection and the progression of HIV infection to AIDS.

M Clerici1, G M Shearer.   

Abstract

Exposure to human immunodeficency virus (HIV) can result in HIV infection which is defined by seroconversion and the detection of HIV-specific antibodies. Nevertheless, in every cohort at risk for HIV infection, individuals are present in whom seroconversion is not observed despite multiple documented exposures to HIV. Recent studies have shown that HIV-specific T-lymphocytes are present in the peripheral blood of these HIV-exposed seronegative individuals, suggesting that cell-mediated immunity (CMI) could have a protective role in the prevention of HIV infection. In most individuals who seroconvert, HIV infection is followed by a long period of clinically asymptomatic latency which ultimately results in the development of acquired immunodeficency syndrome (AIDS). Although this progression is observed in the majority of HIV-infected individuals, individuals exist who are asymptomatic and have relatively high CD4 counts despite long-lasting HIV infection. Analogous to that observed in seronegative HIV-exposed individuals, strong HIV-specific CMI seems to be characteristic of these HIV-seropositive (HIV+) long-term non-progressors (LTNP). Because strong HIV-specific CMI is present in HIV-seronegative individuals exposed to HIV and in HIV+ LTNP, we believe that HIV-specific CMI may be the main correlate of protection against HIV infection and against the progression of HIV infection to AIDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811347     DOI: 10.1016/0165-2478(96)02557-6

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  14 in total

1.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

Authors:  Silvana Tasca; Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Mohammed Saifuddin; Rudolf Bohm; Lisa Chakrabarti; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

3.  Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.

Authors:  J zur Megede; M C Chen; B Doe; M Schaefer; C E Greer; M Selby; G R Otten; S W Barnett
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Reconfigurable microfluidics combined with antibody microarrays for enhanced detection of T-cell secreted cytokines.

Authors:  Arnold Chen; Tam Vu; Gulnaz Stybayeva; Tingrui Pan; Alexander Revzin
Journal:  Biomicrofluidics       Date:  2013-03-14       Impact factor: 2.800

5.  Lensfree holographic imaging of antibody microarrays for high-throughput detection of leukocyte numbers and function.

Authors:  Gulnaz Stybayeva; Onur Mudanyali; Sungkyu Seo; Jaime Silangcruz; Monica Macal; Erlan Ramanculov; Satya Dandekar; Anthony Erlinger; Aydogan Ozcan; Alexander Revzin
Journal:  Anal Chem       Date:  2010-05-01       Impact factor: 6.986

6.  CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects.

Authors:  R Kaul; T Dong; F A Plummer; J Kimani; T Rostron; P Kiama; E Njagi; E Irungu; B Farah; J Oyugi; R Chakraborty; K S MacDonald; J J Bwayo; A McMichael; S L Rowland-Jones
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

7.  Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Authors:  Mohamed Hashem; Hanaa El-Karaksy; Mohamed T Shata; Maha Sobhy; Heba Helmy; Suzan El-Naghi; Gehan Galal; Zainab Z Ali; Gamal Esmat; Sayed F Abdelwahab; G Thomas Strickland; Samer S El-Kamary
Journal:  J Infect Dis       Date:  2011-01-21       Impact factor: 5.226

Review 8.  T helper cell activation and human retroviral pathogenesis.

Authors:  K F Copeland; J L Heeney
Journal:  Microbiol Rev       Date:  1996-12

9.  Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccines.

Authors:  Jan zur Megede; Gillis R Otten; Barbara Doe; Hong Liu; Louisa Leung; Jeffrey B Ulmer; John J Donnelly; Susan W Barnett
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Equine infectious anemia virus is found in tissue macrophages during subclinical infection.

Authors:  J L Oaks; T C McGuire; C Ulibarri; T B Crawford
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.